newdrugapprovals.org
FDA approves new drug to treat multiple sclerosis Ocrevus (ocrelizumab)
FDA approves new drug to treat multiple sclerosis 03/29/2017 On March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multip…